Silverback Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Silverback Therapeutics by Legal & General Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $374k | 35k | 10.55 |
2024-09-30 | $540k | 37k | 14.50 |
2024-06-30 | $294k | 35k | 8.51 |
2024-03-31 | $283k | 28k | 10.22 |
2023-12-31 | $154k | 28k | 5.48 |
2023-09-30 | $106k | 28k | 3.78 |
2023-06-30 | $167k | 25k | 6.70 |
2023-03-31 | $420k | 65k | 6.51 |
2022-03-31 | $6.0k | 1.6k | 3.65 |
2021-12-31 | $11k | 1.6k | 6.70 |
2021-09-30 | $37k | 3.7k | 9.97 |
2021-06-30 | $32k | 1.0k | 30.68 |
2021-03-31 | $57k | 1.3k | 43.58 |
2020-12-31 | $1.0k | 13 | 76.92 |